Cetera Investment Advisers
TNYA icon

Cetera Investment Advisers’s Tenaya Therapeutics TNYA Stock Holding History

Cetera Investment Advisers’s Portfolio TNYA Stock Details TNYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$42.2K Sell
57,125
-12,750
-18% -$9.68K ﹤0.01% 4793
2026
Q1 		$48.4K Sell
69,875
-36,550
-34% -$27K ﹤0.01% 4584
2025
Q4 		$75.7K Buy
106,425
+55,000
+107% +$74.8K ﹤0.01% 4455
2025
Q3 		$83.3K Buy
+51,425
New +$51.8K ﹤0.01% 4360

Other funds holding TNYA

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EAM
Empery Asset Management New York $86.5M AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
BGM
Burkehill Global Management New York $2.77B AUM 65.75% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Cetera Investment Advisers's TNYA Position: Q2 2026 in Review

Cetera Investment Advisers reduced its Tenaya Therapeutics (TNYA) stake by 18% in Q2 2026, selling an estimated $9.68K and leaving 57,125 shares worth $42.2K. The position accounts for ﹤0.01% of the portfolio, ranked #4793.

Cetera Investment Advisers first reported a position in TNYA in Q3 2025 and has held it in 4 quarters since. The position peaked at $83.3K in Q3 2025. 101 funds tracked by Wall St. Rank hold TNYA as of Q2 2026.

  • Cetera Investment Advisers held 57,125 shares of Tenaya Therapeutics worth $42.2K as of Q2 2026.
  • Cetera Investment Advisers sold 12,750 Tenaya Therapeutics shares in Q2 2026, an estimated $9.68K.
  • Tenaya Therapeutics made up ﹤0.01% of Cetera Investment Advisers's portfolio in Q2 2026, its #4793 holding.
  • Cetera Investment Advisers first reported a position in Tenaya Therapeutics in Q3 2025 and has held it in 4 quarters since.
  • Cetera Investment Advisers's Tenaya Therapeutics position peaked at $83.3K in Q3 2025.
  • 101 funds tracked by Wall St. Rank held Tenaya Therapeutics as of Q2 2026.

Based on Cetera Investment Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.